HomeCONGRESS

CONGRESS

View Category
Coronary disease

TCT 2019 | IDEAL-LM: Bioabsorbable Polymer DES vs. Permanent Polymer DES for Left Main Stenosis

Courtesy of SBHCI. This study showed that using the everolimus eluting stent with bioabsorbable polymer Synergy followed by...
solaci -
Learn More
Coronary disease

TCT 2019 | Onyx ONE: Durable Polymer vs. Polymer-Free Stent with Only One Month of Dual Antiplatelet Therapy

Courtesy of the SBHCI. This is the first randomized study comparing a durable-polymer drug-eluting stent (zotarolimus-eluting stent Onyx)...
solaci -
Learn More
Antiplatelet

TCT 2019 | TWILIGHT: Minimal DAPT in High Bleeding Risk Patients

Courtesy of the SBHCI. Monotherapy with a P2Y12 inhibitor after a minimum period (3 months) of dual antiplatelet...
solaci -
Learn More
International Congresses

TCT 2019

Discover the highlights of the 2019 TCT Congress, which took place between September 25th - 29th at...
solaci -
Learn More
Events

Latin American Session at TCT 2019

Yesterday, Wednesday 25th September 2019, took place the session entitled The Best Intervention from Latin América at TCT...
solaci -
Learn More
Events

SOLACI Symposium at SOCIME Congress 2019

SOLACI continues their mission to foster the development of interventional cardiology in Latin America. In this regard,...
solaci -
Learn More
STRUCTURAL HEART DISEASE

ESC 2019 | How Benign Is Moderate Aortic Stenosis?

Data from a great Australian registry of nearly 250,000 people with a 5-year follow-up, presented at the...
solaci -
Learn More
Chronic Ischemic cardiopathy

ESC 2019 | CLARIFY: Symptoms Predict Risk Only in Patients with Prior MI

The 5-year follow up of patients with chronic stable angina (or as the guidelines currently call it...
solaci -
Learn More